Study Stopped
Covid Restrictions have impacted longitudinal assessments for the effect of the intervention
Parkinson's Disease Exercise TMS PET Study
Exercise and Parkinson's Disease: The Basis for Motor and Cognitive Benefits
1 other identifier
interventional
26
1 country
1
Brief Summary
The therapeutic effects of exercise in Parkinson's disease (PD) are commonly reported, however the mechanisms are unknown. The purpose of this study is to investigate the potential mechanisms of exercise in the brain for the treatment of PD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Nov 2014
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2014
CompletedFirst Posted
Study publicly available on registry
October 16, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 12, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 12, 2020
CompletedMarch 17, 2021
March 1, 2021
5.4 years
October 11, 2014
March 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Dopamine release measured by RAC PET
4 months
Study Arms (2)
Exercise 1
ACTIVE COMPARATOROne type of exercise
Exercise 2
PLACEBO COMPARATORA different type of exercise
Interventions
Eligibility Criteria
You may not qualify if:
- atypical Parkinson syndrome (progressive supranuclear palsy, multiple system atrophy, drug-induced etc.);
- significant osteoporosis or arthritis;
- other neurological disease/complications (e.g. myopathy, stroke, brain lesion, MS);
- self-reports claustrophobia;
- history of cancer within 5 years of study participation;
- high dose of radiation from other procedures within the year;
- not able to tolerate being off PD medication for up to 24 hours;
- a female subject who is breast-feeding or pregnant.
- Subjects who regularly use anti-inflammatories (only excluded for PBR scans).
- artificial heart valve;
- brain aneurysm clip;
- electrical stimulator for nerves or bones;
- ear or eye implant;
- implanted drug infusion pump;
- coil, catheter, or filter in any blood vessel;
- +15 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pacific Parkinson's Research Centre
Vancouver, British Columbia, V6T 2B5, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
A.J. Stoessl, MD
Pacific Parkinson's Research Centre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Clinical PET
Study Record Dates
First Submitted
October 11, 2014
First Posted
October 16, 2014
Study Start
November 1, 2014
Primary Completion
March 12, 2020
Study Completion
March 12, 2020
Last Updated
March 17, 2021
Record last verified: 2021-03